Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
Pharmacogenomics, studying genetic variation related to drug response, was established decades ago. Today, performing clinical pharmacogenomics testing has increased, creating great potential to improve patient care. Yet widespread implementation of pharmacogenomics in practice is currently limited, resulting in the "therapeutic odyssey" of patients. Preemptive clinical pharmacogenomics testing prior to the time of prescribing is now emerging as an option that could tailor the pharmacotherapy of patients by increasing drug effectiveness while reducing adverse drug reaction risk.
Center for Individualized Medicine, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
K N
KN
Lazaridis
D064420:Drug-Related Side Effects and Adverse Reactions / Q000517:prevention & control*; D005820:Genetic Testing / Q000379:methods; D014644:Genetic Variation; D006801:Humans; D005791:Patient Care / Q000592:standards; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D010597:Pharmacogenetics / Q000379:methods*; D016896:Treatment Outcome
D004364:Pharmaceutical Preparations